NCT06842056View on ClinicalTrials.gov

Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

Not yet recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

March 31, 2030

Study Completion Date

March 31, 2030

Conditions
Lung Cancer
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY